Physitrack PLC (PTRK) - Net Assets
Based on the latest financial reports, Physitrack PLC (PTRK) has net assets worth Skr9.96 Million SEK (≈ $1.07 Million USD) as of February 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr18.70 Million ≈ $2.01 Million USD) and total liabilities (Skr8.74 Million ≈ $940.78K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Physitrack PLC total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr9.96 Million |
| % of Total Assets | 53.26% |
| Annual Growth Rate | 22.16% |
| 5-Year Change | -65.38% |
| 10-Year Change | 566.58% |
| Growth Volatility | 171.84 |
Physitrack PLC - Net Assets Trend (2014–2025)
This chart illustrates how Physitrack PLC's net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Physitrack PLC to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Physitrack PLC (2014–2025)
The table below shows the annual net assets of Physitrack PLC from 2014 to 2025. For live valuation and market cap data, see PTRK company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-11-30 | Skr9.92 Million ≈ $1.07 Million |
-48.25% |
| 2024-11-30 | Skr19.17 Million ≈ $2.06 Million |
-25.05% |
| 2023-11-30 | Skr25.57 Million ≈ $2.75 Million |
+14.32% |
| 2022-11-30 | Skr22.37 Million ≈ $2.41 Million |
-21.92% |
| 2021-11-30 | Skr28.65 Million ≈ $3.08 Million |
+452.33% |
| 2020-11-30 | Skr5.19 Million ≈ $558.20K |
+405.35% |
| 2019-11-30 | Skr1.03 Million ≈ $110.46K |
-13.91% |
| 2018-11-30 | Skr1.19 Million ≈ $128.31K |
-11.98% |
| 2017-11-30 | Skr1.35 Million ≈ $145.78K |
-8.97% |
| 2016-11-30 | Skr1.49 Million ≈ $160.14K |
-33.28% |
| 2015-11-30 | Skr2.23 Million ≈ $240.01K |
+103.27% |
| 2014-11-30 | Skr1.10 Million ≈ $118.08K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Physitrack PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1380387900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (November 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr63.85K | 0.64% |
| Other Comprehensive Income | Skr-995.21K | -10.00% |
| Other Components | Skr24.85 Million | 249.71% |
| Total Equity | Skr9.95 Million | 100.00% |
Physitrack PLC Competitors by Market Cap
The table below lists competitors of Physitrack PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ESV Inc
KQ:223310
|
$14.11 Million |
|
Euromedis Groupe SA
PA:ALEMG
|
$14.11 Million |
|
MSCM Holdings Bhd
KLSE:0041
|
$14.11 Million |
|
Salona Cotspin Limited
NSE:SALONA
|
$14.12 Million |
|
Image Resources NL
AU:IMA
|
$14.09 Million |
|
Priceworth International Bhd
KLSE:7123
|
$14.09 Million |
|
Minnova Corp
V:MCI
|
$14.09 Million |
|
Argenica Therapeutics Ltd
AU:AGN
|
$14.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Physitrack PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 19,166,000 to 9,951,175, a change of -9,214,825 (-48.1%).
- Net loss of 6,922,870 reduced equity.
- Other comprehensive income decreased equity by 468,132.
- Other factors decreased equity by 1,823,823.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-6.92 Million | -69.57% |
| Other Comprehensive Income | Skr-468.13K | -4.7% |
| Other Changes | Skr-1.82 Million | -18.33% |
| Total Change | Skr- | -48.08% |
Book Value vs Market Value Analysis
This analysis compares Physitrack PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 82.50x to 13.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-11-30 | Skr0.10 | Skr8.06 | x |
| 2015-11-30 | Skr0.20 | Skr8.06 | x |
| 2016-11-30 | Skr0.13 | Skr8.06 | x |
| 2017-11-30 | Skr0.12 | Skr8.06 | x |
| 2018-11-30 | Skr0.11 | Skr8.06 | x |
| 2019-11-30 | Skr0.09 | Skr8.06 | x |
| 2020-11-30 | Skr0.46 | Skr8.06 | x |
| 2021-11-30 | Skr1.70 | Skr8.06 | x |
| 2022-11-30 | Skr1.38 | Skr8.06 | x |
| 2023-11-30 | Skr1.57 | Skr8.06 | x |
| 2024-11-30 | Skr1.18 | Skr8.06 | x |
| 2025-11-30 | Skr0.61 | Skr8.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Physitrack PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -69.57%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -50.26%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 1.92x
- Recent ROE (-69.57%) is below the historical average (-15.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -14.04% | -650.14% | 0.02x | 1.17x | Skr-263.73K |
| 2015 | -19.25% | -973.99% | 0.02x | 1.03x | Skr-652.45K |
| 2016 | -24.17% | -151.38% | 0.12x | 1.35x | Skr-508.43K |
| 2017 | -5.77% | -17.46% | 0.24x | 1.39x | Skr-213.59K |
| 2018 | -17.34% | -24.12% | 0.42x | 1.70x | Skr-325.94K |
| 2019 | -20.06% | -17.14% | 0.66x | 1.77x | Skr-308.56K |
| 2020 | 13.27% | 11.81% | 0.49x | 2.30x | Skr169.71K |
| 2021 | -3.50% | -10.43% | 0.24x | 1.39x | Skr-3.14 Million |
| 2022 | 0.41% | 0.74% | 0.30x | 1.85x | Skr-2.14 Million |
| 2023 | 12.53% | 21.12% | 0.39x | 1.51x | Skr647.52K |
| 2024 | -33.68% | -39.89% | 0.53x | 1.59x | Skr-8.37 Million |
| 2025 | -69.57% | -50.26% | 0.72x | 1.92x | Skr-7.92 Million |
Industry Comparison
This section compares Physitrack PLC's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $183,538,508
- Average return on equity (ROE) among peers: 11.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Physitrack PLC (PTRK) | Skr9.96 Million | -14.04% | 0.88x | $14.10 Million |
| Aino Health AB (AINO) | $1.98 Million | 73.96% | 3.57x | $4.25 Million |
| Carasent ASA (CARA) | $70.28 Million | -60.41% | 1.01x | $171.23 Million |
| Kontigo Care AB (KONT) | $15.40 Million | -8.34% | 0.59x | $5.84 Million |
| Medhelp Care AB (MEDHLP) | $8.68 Million | 33.82% | 4.47x | $22.60 Million |
| RaySearch Laboratories AB (publ) (RAY-B) | $985.30 Million | 23.12% | 1.02x | $580.04 Million |
| Surgical Science Sweden AB (SUS) | $19.60 Million | 8.16% | 1.79x | $190.22 Million |
About Physitrack PLC
Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehe… Read more